(Q52143377)

23 April 2018

title

Practice-related improvement in information processing with novel antipsychotic treatment. (English)

1 reference

23 April 2018

main subject

information processing

1 reference

P D Harvey

1

1 reference

23 April 2018

P J Moriarty

2

1 reference

23 April 2018

M R Serper

3

1 reference

23 April 2018

E Schnur

4

1 reference

23 April 2018

D Lieber

5

1 reference

23 April 2018

language of work or name

English

0 references

publication date

1 December 2000

1 reference

23 April 2018

published in

Schizophrenia Research

1 reference

23 April 2018

volume

46

1 reference

23 April 2018

issue

2-3

1 reference

23 April 2018

page(s)

139-148

1 reference

23 April 2018

Differential effect of low and conventional doses of fluphenazine on schizophrenic outpatients with good or poor information-processing abilities

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900033-5

7 January 2021

Functional magnetic resonance imaging brain mapping in psychiatry: methodological issues illustrated in a study of working memory in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900033-5

7 January 2021

Memory in schizophrenia: what is impaired and what is preserved?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900033-5

7 January 2021

Impaired attention, genetics, and the pathophysiology of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900033-5

7 January 2021

The continuous performance test, identical pairs version: II. Contrasting attentional profiles in schizophrenic and depressed patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900033-5

7 January 2021

Further evidence for dementia of the prefrontal type in schizophrenia? A controlled study of teaching the Wisconsin Card Sorting Test.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900033-5

7 January 2021

What are the functional consequences of neurocognitive deficits in schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900033-5

7 January 2021

Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900033-5

7 January 2021

Does risperidone improve verbal working memory in treatment-resistant schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900033-5

7 January 2021

Cognitive deficits and thought disorder: II. An 8-month followup study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900033-5

7 January 2021

Attentional markers of vulnerability to schizophrenia: performance of medicated and unmedicated patients and normals

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900033-5

7 January 2021

Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900033-5

7 January 2021

The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900033-5

7 January 2021

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900033-5

7 January 2021

Prediction of social skill acquisition in schizophrenic and major affective disorder patients from memory and symptomatology

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900033-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900033-5

7 January 2021

The nature of learning and memory impairments in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900033-5

7 January 2021

Fronto-striato-thalamic perfusion and clozapine response in treatment-refractory schizophrenic patients. A 99mTc-HMPAO study.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900033-5

7 January 2021

Does participation in psychosocial treatment augment the benefit of clozapine? Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900033-5

7 January 2021

Procedural learning of cognitive and motor skills in psychotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900033-5

7 January 2021

Medication may be required for the development of automatic information processing in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900033-5

7 January 2021

Skin-conductance orienting response in chronic schizophrenics: the role of neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900033-5

7 January 2021

10.1016/S0920-9964(00)00033-5

Identifiers

DOI

1 reference

23 April 2018

PubMed ID

11120426

1 reference

23 April 2018